ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue27,390,00020,853,00020,405,00020,247,000
Cost of Revenue11,418,0009,015,0008,729,0009,191,000
Gross Profit15,972,00011,838,00011,676,00011,056,000
Operating Expenses
Research Development2,158,0001,358,0001,371,0001,286,000
Selling General and Administrative8,899,0006,653,0006,742,0006,327,000
Non Recurring----
Others----
Total Operating Expenses24,450,00017,576,00017,443,00017,359,000
Operating Income or Loss2,940,0003,277,0002,962,0002,888,000
Income from Continuing Operations
Total Other Income/Expenses Net-709,000-1,864,000221,000-370,000
Earnings Before Interest and Taxes2,940,0003,277,0002,962,0002,888,000
Interest Expense-904,000-431,000-163,000-150,000
Income Before Tax2,231,0001,413,0003,183,0002,518,000
Income Tax Expense1,878,000350,000577,000797,000
Minority Interest201,000179,000115,000113,000
Net Income From Continuing Ops353,0001,063,0002,606,0001,721,000
Non-recurring Events
Discontinued Operations124,000337,0001,817,000563,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income477,0001,400,0004,423,0002,284,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares468,0001,393,0004,403,0002,273,000